Page 147 - IJB-10-1

International Journal of Bioprinting Bioprinting organoids for toxicity testing

therapeutic options and targeting chemoresistance. Clin Res 34. Hong N, Yang GH, Lee J, et al. 3D bioprinting and its in
Hepatol Gastroenterol. 2022;46(5):101911. vivo applications. J Biomed Mater Res B Appl Biomater.
doi: 10.1016/j.clinre.2022.101911 2018;106(1):444-459.
doi: 10.1002/jbm.b.33826
23. Han X, Zhang WH, Wang WQ, et al. Cancer-associated
fibroblasts in therapeutic resistance of pancreatic cancer: 35. Yu S, Wang M, Zhang H, et al. Circ_0092367 inhibits
Present situation, predicaments, and perspectives. Biochim EMT and gemcitabine resistance in pancreatic cancer
Biophys Acta Rev Cancer. 2020;1874(2):188444. via regulating the miR-1206/ESRP1 axis. Genes (Basel).
doi: 10.1016/j.bbcan.2020.188444 2021;12(11):1701.
doi: 10.3390/genes12111701
24. Sheikh R, Walsh N, Clynes M, et al. Challenges of drug
resistance in the management of pancreatic cancer. Expert 36. Szlasa W, Michel O, Sauer N, et al. Nanosecond pulsed electric
Rev Anticancer Ther. 2010;10(10):1647-1661. field suppresses growth and reduces multi-drug resistance
doi: 10.1586/era.10.148 effect in pancreatic cancer. Sci Rep. 2023;13(1):351.
doi: 10.1038/s41598-023-27605-4
25. Long J, Zhang Y, Yu X, et al. Overcoming drug resistance in
pancreatic cancer. Expert Opin Ther Targets. 2011;15(7):817- 37. Cui J, Jiang W, Wang S, et al. Role of Wnt/β-catenin signaling
828. in drug resistance of pancreatic cancer. Curr Pharm Des.
doi: 10.1517/14728222.2011.566216 2012;18(17):2464-2471.
doi: 10.2174/13816128112092464
26. Hakobyan D, Médina C, Dusserre N, et al. Laser-assisted 3D
bioprinting of exocrine pancreas spheroid models for cancer 38. Liang C, Shi S, Meng Q, et al. Complex roles of the stroma
initiation study. Biofabrication. 2020;12(3):035001. in the intrinsic resistance to gemcitabine in pancreatic
doi: 10.1088/1758-5090/ab7cb8 cancer: Where we are and where we are going. Exp Mol Med.
2017;49(12):e406.
27. Kuo YC, Kou HW, Hsu CP, et al. Identification and clinical doi: 10.1038/emm.2017.255
significance of pancreatic cancer stem cells and their
chemotherapeutic drug resistance. Int J Mol Sci. 2023; 39. Rahnama N, Jahangir M, Alesaeid S, et al. Association
24(8):7331. between microRNAs and chemoresistance in pancreatic
doi: 10.3390/ijms24087331 cancer: Current knowledge, new insights, and forthcoming
perspectives. Pathol Res Pract. 2022;236: 153982.
28. Capurso G, Sette C. Drug resistance in pancreatic cancer: doi: 10.1016/j.prp.2022.153982
New player caught in act. EBioMedicine. 2019;40: 39-40. 40. Chen Q, Wang Q, Wang Y, et al. Penetrating micelle
doi: 10.1016/j.ebiom.2019.02.008
for reversing immunosuppression and drug resistance
29. Beatty GL, Werba G, Lyssiotis CA, et al. The biological in pancreatic cancer treatment. Small. 2022;18(18):
underpinnings of therapeutic resistance in pancreatic e2107712.
cancer. Genes Dev. 2021;35(13-14):940-962. doi: 10.1002/smll.202107712
doi: 10.1101/gad.348523.121 41. Gurlin RE, Giraldo JA, Latres E. 3D bioprinting and
30. Gungor-Ozkerim PS, Inci I, Zhang YS, Khademhosseini A, translation of beta cell replacement therapies for type 1
Dokmeci MR. Bioinks for 3D bioprinting: An overview. diabetes. Tissue Eng Part B Rev. 2021;27(3):238-252.
Biomater Sci. 2018;6(5):915-946. doi: 10.1089/ten.TEB.2020.0192
doi: 10.1039/c7bm00765e 42. Klak M, Kowalska P, Dobrzański T, et al. Bionic organs: Shear
31. Fitzgerald TL, McCubrey JA. Pancreatic cancer stem cells: forces reduce pancreatic islet and mammalian cell viability
Association with cell surface markers, prognosis, resistance, during the process of 3D bioprinting. Micromachines (Basel).
metastasis and treatment. Adv Biol Regul. 2014;56: 2021;12(3):304.
45-50. doi: 10.3390/mi12030304
doi: 10.1016/j.jbior.2014.05.001 43. Duin S, Schütz K, Ahlfeld T, et al. 3D bioprinting of
32. Okazaki J, Tanahashi T, Sato Y, et al. MicroRNA-296-5p functional islets of langerhans in an alginate/methylcellulose
promotes cell invasion and drug resistance by targeting hydrogel blend. Adv Healthc Mater. 2019;8(7):e1801631.
Bcl2-related ovarian killer, leading to a poor prognosis in doi: 10.1002/adhm.201801631
pancreatic cancer. Digestion. 2020;101(6):794-806. 44. Shim IK, Yi HJ, Yi HG, et al. Locally-applied 5-fluorouracil-
doi: 10.1159/000503225 loaded slow-release patch prevents pancreatic cancer
33. Zhan T, Chen X, Tian X, et al. MiR-331-3p links to drug growth in an orthotopic mouse model. Oncotarget,
resistance of pancreatic cancer cells by activating WNT/β- 2017;8(25):40140-40151.
catenin signal via ST7L. Technol Cancer Res Treat. 2020;19: doi: 10.18632/oncotarget.17370
1533033820945801. 45. Lee EM, Jung JI, Alam Z, et al. Effect of an oxygen-
doi: 10.1177/1533033820945801 generating scaffold on the viability and insulin secretion

Volume 10 Issue 1 (2024) 139 https://doi.org/10.36922/ijb.1256